Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes

Hemorrhagic transformation is an important complication of acute ischemic stroke, particularly in diabetic patients receiving thrombolytic treatment with tissue plasminogen activator, the only approved drug for the treatment of acute ischemic stroke. The objective of the present study was to determi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kelly-Cobbs, Aisha I., Prakash, Roshini, Li, Weiguo, Pillai, Bindu, Hafez, Sherif, Coucha, Maha, Johnson, Maribeth H., Ogbi, Safia N., Fagan, Susan C., Ergul, Adviye
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Physiological Society 2013
Gaiak:
Vascular Biology and Microcirculation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3602773/
https://ncbi.nlm.nih.gov/pubmed/23335797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00720.2012
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak